AU1459500A - Dihydropyridine compounds and methods of use - Google Patents

Dihydropyridine compounds and methods of use

Info

Publication number
AU1459500A
AU1459500A AU14595/00A AU1459500A AU1459500A AU 1459500 A AU1459500 A AU 1459500A AU 14595/00 A AU14595/00 A AU 14595/00A AU 1459500 A AU1459500 A AU 1459500A AU 1459500 A AU1459500 A AU 1459500A
Authority
AU
Australia
Prior art keywords
methods
dihydropyridine compounds
dihydropyridine
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14595/00A
Inventor
Konstantinos A. Agrios
Fatima Z. Basha
William A Carroll
Yiyuan Chen
Michael E. Kort
Philip R. Kym
Rui Tang
Sean C. Turner
Lin Yi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU1459500A publication Critical patent/AU1459500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU14595/00A 1998-10-28 1999-10-28 Dihydropyridine compounds and methods of use Abandoned AU1459500A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18123998A 1998-10-28 1998-10-28
US09181239 1998-10-28
US42191299A 1999-10-20 1999-10-20
US09421912 1999-10-20
PCT/US1999/025536 WO2000024741A2 (en) 1998-10-28 1999-10-28 Dihydropyridine compounds and their use as potassium channel openers

Publications (1)

Publication Number Publication Date
AU1459500A true AU1459500A (en) 2000-05-15

Family

ID=26877009

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14595/00A Abandoned AU1459500A (en) 1998-10-28 1999-10-28 Dihydropyridine compounds and methods of use

Country Status (6)

Country Link
EP (1) EP1131322A2 (en)
JP (1) JP2002528452A (en)
AU (1) AU1459500A (en)
CA (1) CA2348165A1 (en)
HK (1) HK1041878A1 (en)
WO (1) WO2000024741A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191140B1 (en) * 1998-10-28 2001-02-20 Abbott Laboratories Pyrano, piperidino, and thiopyrano compounds and methods of use
US6538004B2 (en) 2000-03-03 2003-03-25 Abbott Laboratories Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
JP2003525939A (en) * 2000-03-03 2003-09-02 アボット・ラボラトリーズ Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
MXPA02010807A (en) * 2000-05-02 2003-04-14 Abbott Lab Dihydropyridine compounds and methods of use.
CN114516774A (en) * 2021-02-08 2022-05-20 中国科学院成都生物研究所 Preparation method of chiral bromo-1, 4-dihydropyridine compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9220570D0 (en) * 1991-10-21 1992-11-11 Ici Plc Therapeutic agent
CA2080949A1 (en) * 1991-10-21 1993-04-22 Cyrus John Ohnmacht Therapeutic agents
GB9318935D0 (en) * 1992-10-20 1993-10-27 Zeneca Ltd Heterocyclic derivatives
DE4430092A1 (en) * 1994-08-25 1996-02-29 Bayer Ag 2,3-Cyclically condensed 1,4-dihydropyridines, process for their preparation and their use as medicaments
DE4444864A1 (en) * 1994-12-16 1996-06-20 Bayer Ag Use of 5-acyl-1,4-dihydropyridines
TR200001715T2 (en) * 1997-12-18 2000-12-21 Abbott Laboratories Potassium channel openers.

Also Published As

Publication number Publication date
WO2000024741A3 (en) 2000-07-13
WO2000024741A2 (en) 2000-05-04
JP2002528452A (en) 2002-09-03
CA2348165A1 (en) 2000-05-04
EP1131322A2 (en) 2001-09-12
HK1041878A1 (en) 2002-07-26

Similar Documents

Publication Publication Date Title
AU6111699A (en) Novel method and compounds
AU2886399A (en) Intraluminal shunt and methods of use
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU9790198A (en) Compounds and methods
AU6079598A (en) Additive preparation and method of use thereof
AU6117000A (en) Novel polynucleotides and method of use thereof
AU7710198A (en) Single pass lead and method of use
AU7989400A (en) Compounds and methods
AU3215500A (en) Compounds and methods
AU3514299A (en) Method of providing secure user access
AU4261697A (en) Compounds and methods
AU2349399A (en) R-lansoprazole compositions and methods
AU4198299A (en) Compounds and uses thereof
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU3551399A (en) Calcilytic compounds and method of use
WO2001041823A8 (en) Radioactive compositions and methods of use thereof
AU2330599A (en) Fluorinated oxyvinyl compounds and methods of preparing and using same
AU6270799A (en) Firestarter and method of making same
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU3936699A (en) Novel vinca-alkaloid derivatives and preparation method
AU2962400A (en) Cleaner composition and method of use thereof
AU2333099A (en) Aryloxyanilides and related compounds
AU1812601A (en) Cover member and method of making same
AU1907100A (en) Omeprazole solution and method of using same
AU1459500A (en) Dihydropyridine compounds and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase